Target intelligence / Profile preview

O6 position of guanine in DNA

Molecular classification
Other (Atom or functional group in nucleic acid base)
01

Overview

The O6 position of guanine is an oxygen atom bonded to the C6 carbon on guanine, one of the four nucleobases in DNA. Alkylation at this position (as in O6-methylguanine) is a major mutagenic lesion that can cause transition mutations (G:C to A:T) if left unrepaired. Such alkylated guanines mispair with thymine during DNA replication. The DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) removes alkyl groups from this position, protecting the genome from alkylation-induced mutagenesis and carcinogenesis. In cancer therapy, alkylating agents intentionally produce O6-methylguanine to induce tumor cell death; however, elevated MGMT levels can confer chemoresistance. These lesions also activate DNA damage response pathways that can trigger cell cycle arrest and apoptosis, particularly in the absence of sufficient MGMT-mediated repair.

Other names
O6 atom of guanineO6-guanyl groupO6-guanine lesionO6-methylguanine
02

Mechanism of action

Alkylating agents transfer an alkyl (commonly methyl) group onto the O6 atom of guanine, causing mispairing (G:C to A:T transitions) and cytotoxicity. DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) removes alkyl groups from the O6 position, preventing mutations.

03

Biological functions

DNA alkylation siteMutation hotspotDNA adduct formation
04

Disease associations

CancerOther (DNA damage response, apoptosis)
05

Safety considerations

DNA alkylation at O6 can increase mutagenesis, carcinogenicity, and cell deathRepair saturation (limit to how much MGMT is available for repair; excess alkylation can lead to toxicity)
06

Interacting drugs

Alkylating agents (e.g., temozolomide, nitrosoureas like BCNU) create O6-methylguanine lesions in DNA that interact indirectly by modifying the site
07

Biomarkers

O6-methylguanine formation (used as a biomarker for alkylating DNA damage)MGMT protein expression or promoter methylation (determines cell sensitivity to alkylating chemotherapy)

Beyond the preview

Go deeper on O6 position of guanine in DNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on O6 position of guanine in DNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call